Genetikos ir molekulinės medicinos draugija - company info and details
Company age: 2 y. 7 mo.
Company overview
Basic information
Company name
Genetikos ir molekulinės medicinos draugija
Company code
306702789
Registered address
Kauno r. sav., Samylų sen., Laumėnų k., Beržų g. 16, LT-53135
Registration date
2024-03-26
Company age: 2 y. 7 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Not disclosed
(personal)
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Association
NACE activity
Activities of other membership organisations n.e.c.
Sector
Namų ūkiams paslaugas teikiančios ne pelno institucijos
Ownership form
Private without foreign capital
Beneficiary of support
Yes, since 2025-03-12
NVO
Non-governmental organization since 2025-03-24
Genetikos ir molekulinės medicinos draugija
Company code: 306702789
Address: Kauno r. sav., Samylų sen., Laumėnų k., Beržų g. 16, LT-53135
Description
This description was generated by artificial intelligence.
Genetikos ir molekulines medicinos draugija (company code 306702789) is an operational public association registered on 26 March 2024. It operates as a non-profit institution providing services to households, with private ownership, and is governed by a CEO with a board/council. The entity is classified as micro-sized. Its registered address is Beržu g. 16, Laumenu k., Samylai eldership, Kaunas District Municipality, Kaunas County. The company’s EVRK activity code is T.94.99.00, covering Activities of other membership organisations n.e.c. Financially, the association reported revenue of €200 in 2024 for a 280-day period and ended that year with €200 in net profit, equity and total assets. In 2025, for a full 364-day financial year, revenue increased to €10.9K and total assets reached €8.0K. The latest figures show a strong increase in turnover from the initial year of operations.
Download a detailed company report
Make confident decisions with all the information about Genetikos ir molekulinės medicinos draugija. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.